Effects of baicalein on Sendai virus in vivo are linked to serum baicalin and its inhibition of hemagglutinin-neuraminidase. (Q45369417)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21286764%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Effects of baicalein on Sendai virus in vivo are linked to serum baicalin and its inhibition of hemagglutinin-neuraminidase (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21286764%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

0 references

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21286764%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Jie Dou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21286764%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Lili Chen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21286764%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Ge Xu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21286764%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Lei Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21286764%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Huimin Zhou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21286764%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Hui Wang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21286764%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Zhenzhen Su

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21286764%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Qinglong Guo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21286764%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Changlin Zhou

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21286764%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

1 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21286764%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21286764%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21286764%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21286764%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

793-801

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21286764%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00705-011-0917-z

21 January 2020

exact match

0 references

cites work

Epidemiology and cost of infection with human parainfluenza virus types 1 and 2 in young children

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z

Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z

Comparison of metabolic pharmacokinetics of baicalin and baicalein in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z

Interaction of baicalin and baicalein with antibiotics in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z

Inhibitory effects of baicalein on the influenza virus in vivo is determined by baicalin in the serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z

The use of MDCK, MEK and LLC-MK2 cell lines with enzyme immunoassay for the isolation of influenza and parainfluenza viruses from clinical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z

Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z

Influence of time of administration of a Shosaiko-to extract granule on blood concentration of its active constituents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z

Anti-HIV activity of medicinal herbs: usage and potential development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z

Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z

Baicalein protects rat cardiomyocytes from hypoxia/reoxygenation damage via a prooxidant mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z

Baicalein, a component of Scutellaria radix from Huang-Lian-Jie-Du-Tang (HLJDT), leads to suppression of proliferation and induction of apoptosis in human myeloma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z

Monoclonal antibodies to human parainfluenza virus type 1 detect major antigenic changes in clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z

Oseltamivir resistance during treatment of influenza A (H5N1) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z

Avian flu: isolation of drug-resistant H5N1 virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z

Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z

Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z

Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z

Combination treatment of influenza A virus infections in cell culture and in mice with the cyclopentane neuraminidase inhibitor RWJ-270201 and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z

Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z

Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z

Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-011-0917-Z